1. Home
  2. KNSA vs TDC Comparison

KNSA vs TDC Comparison

Compare KNSA & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • TDC
  • Stock Information
  • Founded
  • KNSA 2015
  • TDC 1979
  • Country
  • KNSA United Kingdom
  • TDC United States
  • Employees
  • KNSA N/A
  • TDC N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • TDC Computer Software: Prepackaged Software
  • Sector
  • KNSA Health Care
  • TDC Technology
  • Exchange
  • KNSA Nasdaq
  • TDC Nasdaq
  • Market Cap
  • KNSA 1.9B
  • TDC 2.1B
  • IPO Year
  • KNSA 2018
  • TDC 2007
  • Fundamental
  • Price
  • KNSA $27.36
  • TDC $21.95
  • Analyst Decision
  • KNSA Strong Buy
  • TDC Hold
  • Analyst Count
  • KNSA 5
  • TDC 9
  • Target Price
  • KNSA $38.80
  • TDC $30.00
  • AVG Volume (30 Days)
  • KNSA 474.9K
  • TDC 1.1M
  • Earning Date
  • KNSA 07-22-2025
  • TDC 05-06-2025
  • Dividend Yield
  • KNSA N/A
  • TDC N/A
  • EPS Growth
  • KNSA N/A
  • TDC 241.18
  • EPS
  • KNSA N/A
  • TDC 1.41
  • Revenue
  • KNSA $481,166,000.00
  • TDC $1,703,000,000.00
  • Revenue This Year
  • KNSA $37.21
  • TDC N/A
  • Revenue Next Year
  • KNSA $5.32
  • TDC $0.97
  • P/E Ratio
  • KNSA N/A
  • TDC $15.55
  • Revenue Growth
  • KNSA 59.45
  • TDC N/A
  • 52 Week Low
  • KNSA $17.38
  • TDC $18.43
  • 52 Week High
  • KNSA $28.56
  • TDC $35.60
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 62.48
  • TDC 47.91
  • Support Level
  • KNSA $26.28
  • TDC $21.42
  • Resistance Level
  • KNSA $27.90
  • TDC $22.11
  • Average True Range (ATR)
  • KNSA 0.99
  • TDC 0.43
  • MACD
  • KNSA -0.07
  • TDC -0.11
  • Stochastic Oscillator
  • KNSA 82.30
  • TDC 23.45

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About TDC Teradata Corporation

Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.

Share on Social Networks: